The follow-up of patients treated for breast carcinoma has been frequently discussed in the recent literature. Intensive follow-up of patients under research treatment protocols is justified, but this has become common practice. Studies performed until now do not show any usefulness for the patient's outcome, especialty survival, of intensive follow-up, except possibly in some special situations. Bone scintigrams are not recommended any more as a follow-up exam. Laboratory examinations can be limited to complete blood count sedimentation rate, alkaline phosphatase, GOT transaminase, Gamma-GT and possibly calcium and creatinine. Follow-up of tumour markets, chest X-rays, liver ultrasound, are possibly useful only in patients who might benefit from intensive chemotherapy in case of early detection of metastatic disease. Patients followed for breast cancers with an excellent prognosis (more than 90% survival) are probably not candidates for a very intensive follow-up.
|Translated title of the contribution||Usefulness or not of follow-up in breast cancer|
|Number of pages||3|
|Journal||Medecine et Hygiene|
|Publication status||Published - 1996|
ASJC Scopus subject areas